PeptidePedia The community reference

SURMOUNT trial programme: difference between revisions

Diff·revision 14 → 15·12:33, 10 Mar 2025

Difference between revision 14 and revision 15 of SURMOUNT trial programme. This revision changed no lines of source — the edit was a null or whitespace change.

Revision 14 — 11:26, 16 Feb 2025
GlossaryGleb (talk)
add the discontinuation rate for adverse events in both arms
3,559 bytes +289
Revision 15 — 12:33, 10 Mar 2025
SurpassSunniva (talk)
add the PMID
3,559 bytes ±0
No change to the page source.